Benitec Biopharma Inc. (BNTC) Operating margin 2019–2023
Benitec Biopharma Inc. (BNTC) operating margin by fiscal year — reported operating income divided by reported revenue.
-25441.3%FY2023 · since FY2019: 21.2% → -25441.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -25441.3% | -983.8 pp |
| FY2022 | -24457.5% | -1413.5 pp |
| FY2021 | -23044.1% | -14925.4 pp |
| FY2020 | -8118.6% | -8139.8 pp |
| FY2019 | 21.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice